Transverse Medical develops POINT‑GUARD cerebral embolic protection for TAVR and other transcatheter procedures, conducting TGA feasibility trials and scaling engineering, regulatory, quality, and operations toward FDA IDE submission.
Part of: Denver Startups by Fundable